Recently, fructose 1,6-bisphosphate (FBP), a glycolytic intermediate, was found to be accumulated in ccRCC, leading to the suppression of NADPH oxidase 4 (NOX4), which caused an increase in NADPH and a decrease in ROS, independent of PPP [80]. Here, NOX4 is linked to nonpapillary renal cell carcinoma.